Thelansis: Market Research Reports

The Team

Thelansis is the brain-child of specialized experts with multiple years of experience in healthcare management consulting.
Our core team is comprised of esteemed professionals, including reputed physicians, business analysts, and biotechnologists.
Thelansis combines global expertise and insight, with a rich mix of scientific and business development backgrounds.
We are guided by a strong set of values, including a commitment to professional diversity.

The Target

Our team strives to provide organizations with exceptional market research that will inform strategic business decisions.
We partner with organizations to help support their vision, and maintain a reputation as a Valued Knowledge Partner.

Publications found: 321

Sort by:

Primary Progressive Multiple Sclerosis (Ppms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Primary Progressive Multiple Sclerosis (PPMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 196 pages

Pruritus - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pruritus' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 192 pages

Psoriatic Arthritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Psoriatic Arthritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 189 pages

Pulmonary Embolism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pulmonary Embolism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 214 pages

Pyelonephritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pyelonephritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 146 pages

Radiation Toxicity - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Radiation Toxicity' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 192 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Recurrent Head And Neck Cancer Squamous Cell Carcinoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, ...

March 2018 213 pages

Relapsed Chronic Lymphocytic Leukemia (Cll) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Relapsed Chronic Lymphocytic Leukemia (CLL)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 159 pages

Relapsing Multiple Sclerosis (Rms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Relapsing Multiple Sclerosis (RMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 199 pages

Restless Legs Syndrome - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Restless Legs Syndrome' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 156 pages

Retinal Vein Occlusion - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Retinal Vein Occlusion' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 155 pages

Rhino-Conjunctivitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Rhino-Conjunctivitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 219 pages

Rosacea - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Rosacea' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 168 pages

Sarcoidosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Sarcoidosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 169 pages

Schistosomiasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Schistosomiasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 164 pages

Seasonal Allergic Rhinitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Seasonal Allergic Rhinitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2018 204 pages

Secondary Hyperparathyroidism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Secondary Hyperparathyroidism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2018 199 pages

Secondary Progressive Multiple Sclerosis (Spms) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Secondary Progressive Multiple Sclerosis (SPMS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2018 145 pages

Sedation - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Sedation' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2018 165 pages

Adrenoleukodystrophy - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Adrenoleukodystrophy' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 175 pages

Non Alcoholic Fatty Liver Disease (Nafld) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

... Partners 'Non Alcoholic Fatty Liver Disease (NAFLD)' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of the Disease overview ... market based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, reimbursement ...

December 2017 225 pages

Neuroendocrine Tumor(Net) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Neuroendocrine Tumor(NET)' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2017 268 pages

Neurotrophic Keratitis - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Neurotrophic Keratitis' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 167 pages

Niemann-Pick Disease Type C (Npc) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

... Partners 'Niemann-Pick Disease type C' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of the Disease overview, ... . Key patient segment and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy ...

December 2017 152 pages

Gastrointestinal Neuroendocrine Tumors (Gi Nets) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Gastrointestinal Neuroendocrine tumors (GI NETs)' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to ...

December 2017 235 pages

Pancreatic Net (P Net) - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Pancreatic NET (P NET)' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to ...

December 2017 232 pages

Idiopathic Pulmonary Fibrosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Idiopathic Pulmonary Fibrosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 207 pages

Idiopathic Short Stature - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Idiopathic Short Stature' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 158 pages

Idiopathic Thrombocytopenic Purpura - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Idiopathic Thrombocytopenic Purpura' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2017 185 pages

Impetigo - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Impetigo' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 185 pages

Indolent Lymphoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Indolent Lymphoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 184 pages

Infantile Spasm - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Infantile Spasm' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 191 pages

Influenza A Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Influenza A Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 219 pages

Insulin Resistance - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Insulin Resistance' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 219 pages

Intermittent Claudication - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Intermittent Claudication' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 215 pages

Iron Deficiency Anemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Iron Deficiency Anemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 174 pages

Iron Overload Disorder - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Iron Overload Disorder' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 138 pages

Ischemic Stroke - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Ischemic Stroke' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 212 pages

Juvenile Rheumatoid Arthritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Juvenile Rheumatoid Arthritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 177 pages

Kaposi'S Sarcoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Kaposi's Sarcoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 165 pages

Klebsiella Pneumoniae Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Klebsiella Pneumoniae Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 176 pages

Left Ventricular Dysfunction - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Left Ventricular Dysfunction' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 196 pages

Leishmaniasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Leishmaniasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 200 pages

Liposarcoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Liposarcoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 203 pages

Liver Failure - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Liver Failure' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 200 pages

Lupus Nephritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Lupus Nephritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 215 pages

Male Hypogonadism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Male Hypogonadism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 168 pages

Malignant Glioma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Malignant Glioma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 171 pages

Malignant Mesothelioma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Malignant Mesothelioma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 198 pages

Medullary Thyroid Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Medullary Thyroid Cancer ' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 173 pages